Results 71 to 80 of about 8,269 (200)

Reciprocal translocation t(2;12)(q31;p13) in a case of CMML [PDF]

open access: yes, 2007
Case report of a translocation : Reciprocal translocation t(2;12)(q31;p13) in a case of ...
Fisfis, M   +3 more
core   +1 more source

Evaluation of Methods for Identifying Human Monocytes by Flow Cytometry: TLR2 May be an Optimal Marker

open access: yesImmunology, Volume 179, Issue 4, Page 682-694, December 2026.
Monocytes play crucial roles in the pathobiology of a wide range of medical conditions, including infection, autoimmunity, cardiovascular disease and malignancies. Studies using flow cytometry revealed the complexity of monocyte biology, including the identification of three human monocyte subsets: classical (CD14pos CD16neg), intermediate (CD14pos ...
Mie Wolff Kristensen   +4 more
wiley   +1 more source

PLC/JNK/ERK Ingenuity Pathway network containing differentially methylated genes between CMML patients and healthy donor samples.

open access: yes, 2012
Red: hypermethylated in CMML samples; Green: hypomethylated in CMML samples.
Jacqueline Boultwood (89560)   +16 more
core   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, Volume 20, Issue 11, Page 2860-2875, November 2026.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Chronische Myelomonozytäre Leukämie (CMML)

open access: yes
Chronische Myelomonozytäre Leukämien (CMML) werden basierend auf dem Nachweis von Monozyten im Blut verbunden mit Dysplasien im Knochenmark nach Ausschluss zahlreicher reaktiver Monozytosen diagnostiziert.
Schweizerische Gesellschaft für Hämatologie   +10 more
core   +2 more sources

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.

open access: yesPLoS ONE, 2012
Chronic myelomonocytic leukemia (CMML) has recently been associated with a high incidence of diverse mutations in genes such as TET2 or EZH2 that are implicated in epigenetic mechanisms. We have performed genome-wide DNA methylation arrays and mutational
Cristina Pérez   +16 more
doaj   +1 more source

A New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma

open access: yes, 2016
Introduction: CMML is a clinically heterogeneous myeloid neoplasm hallmarked by the coexistence of dysplastic and proliferative patho-clinical features, which can include cytopenias, constitutional symptoms, splenomegaly, and leukocytosis.
Aziz Nazha   +20 more
core   +2 more sources

Refining the boundary between myelodysplastic neoplasm and chronic myelomonocytic leukaemia under World Health Organization 2022 criteria using open‐source data

open access: yes
British Journal of Haematology, EarlyView.
Jiwon Yun   +5 more
wiley   +1 more source

Modulation of the RNA‐sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia

open access: yesHemaSphere, Volume 10, Issue 11, November 2026.
Abstract DNA hypomethylating agents (HMAs) such as 5‐azacytidine (5‐AZA) are a cornerstone in the treatment of acute myeloid leukemia (AML), but development of resistance represents a major clinical challenge. Apart from epigenetic reprogramming of malignant cell clones, therapy with HMA is increasingly recognized to facilitate antineoplastic immunity,
Nadia El Khawanky   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy